Items where authors include "Buckland, M"
Up a levelArticle
Abani, O, Abbas, A, Abbas, F et al. (6300 more authors) (2022) Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 399 (10325). pp. 665-676. ISSN 0140-6736
Brown, L-AK, Moran, E, Goodman, A et al. (19 more authors) (2021) Treatment of chronic or relapsing COVID-19 in immunodeficiency. Journal of Allergy and Clinical Immunology, 149 (2). pp. 557-561. ISSN 0091-6749
Abani, O, Abbas, A, Abbas, F et al. (4809 more authors) (2021) Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial. The Lancet, 397 (10289). pp. 2049-2059. ISSN 0140-6736
Abani, O orcid.org/0000-0003-2209-9956, Abbas, A, Abbas, F et al. (6346 more authors) (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 397 (10285). pp. 1637-1645. ISSN 0140-6736
Abolhassani, H, El-Sherbiny, YM orcid.org/0000-0003-4791-3475, Arumugakani, G et al. (12 more authors) (2020) Expanding Clinical Phenotype and Novel Insights into the Pathogenesis of ICOS Deficiency. Journal of Clinical Immunology, 40. pp. 277-288. ISSN 0271-9142
Aldape, K, Amin, SB, Ashley, DM et al. (54 more authors) (2018) Glioma Through the Looking GLASS: Molecular Evolution of Diffuse Gliomas and the Glioma Longitudinal AnalySiS Consortium. Neuro-Oncology, 20 (7). pp. 873-884. ISSN 1522-8517
Shillitoe, B, Bangs, C, Guzman, D et al. (30 more authors) (2018) The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017. Clinical and Experimental Immunology, 192 (3). pp. 284-291. ISSN 0009-9104
Maccari, ME, Abolhassani, H, Aghamohammadi, A et al. (64 more authors) (2018) Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry. Frontiers in Immunology, 9. 543. ISSN 1664-3224